Nisa Investment Advisors
ALBO

Nisa Investment Advisors’s Albireo Pharma Inc ALBO Stock Holding History

Nisa Investment Advisors’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-24
Closed -$1K – 2803
2022
Q4 		$1K Hold
24
– – ﹤0.01% 2562
2022
Q3 		$1K Buy
+24
New +$496 ﹤0.01% 2564

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nisa Investment Advisors's ALBO Position: Q1 2023 in Review

Nisa Investment Advisors sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 24 shares — an estimated $1K sold.

Nisa Investment Advisors first reported a position in ALBO in Q3 2022 and held it in 2 quarters. The position peaked at $1K in Q4 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • Nisa Investment Advisors reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • Nisa Investment Advisors sold 24 Albireo Pharma Inc shares in Q1 2023, an estimated $1K.
  • Nisa Investment Advisors first reported a position in Albireo Pharma Inc in Q3 2022 and held it in 2 quarters.
  • Nisa Investment Advisors's Albireo Pharma Inc position peaked at $1K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Nisa Investment Advisors's 13F filing for Q1 2023, filed 2 May 2023.